Laurel Wealth Planning’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,150
Closed -$119K 81
2022
Q4
$119K Hold
1,150
0.08% 76
2022
Q3
$97K Hold
1,150
0.07% 80
2022
Q2
$95K Hold
1,150
0.07% 81
2022
Q1
$89K Buy
+1,150
New +$89K 0.06% 97